MEG Biomarkers in relation to plasma neuropathology biomarkers of Alzheimer’s disease

Alejandra García‐Colomo · 2025

Read MEG Biomarkers in relation to plasma neuropathology biomarkers of Alzheimer’s disease by Alejandra García‐Colomo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716108.txt.

Description

Alejandra García-Colomo links brain network maps to blood markers of Alzheimer's disease in people with no symptoms, in a study published in 2025. The disease's preclinical stage is a prime window for early detection, but brain scans and spinal fluid tests are invasive or costly. Thirty-three cognitively normal people with raised blood levels of two pathology markers underwent MEG brain recordings. A compound score rated each brain region's importance in the network.

Rising levels of one marker, phosphorylated tau 231, tracked with greater importance of rear brain areas in slow theta rhythms and less in fast gamma rhythms on the left. The most central regions showed the strongest marker links, suggesting hubs are hit first. The author frames the results as early evidence that network communication shifts before symptoms. Such combined blood-plus-brain signatures could one day flag risk cheaply.

Catalog record

CREATORAlejandra García‐Colomo
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11716108

Browse the full library · About the Tower of Babel